A look at Exact Sciences Corporation’s acquisition by Abbott: review EXAS revenue growth, margins, and CRC/MRD screening ...

Ozempic and Wegovy might help people avoid colon cancer as well as promote weight loss or control diabetes, a new study says.

(NEXSTAR) — An unexpected delivery at your door may not always be an unwelcome surprise — just ask one Kentucky boy about the thousands of dollars worth of lollipops that arrived at his home earlier ...

A blood test could help doctors decide which patients with colon cancer should receive anti-inflammatory medication along with chemotherapy after surgery, according to a study appearing in JAMA ...

A blood test could help doctors decide which patients with colon cancer should receive anti-inflammatory medication along with chemotherapy after surgery, according to new study in JAMA Oncology.

Tucson’s PGA Tour Champions event will have a title sponsor for at least several more years. The tour and Exact Sciences, the makers of title sponsor Cologuard, announced a five-year extension of the ...

(NewsNation) — More than 150,000 cases of colorectal cancer are estimated to have been diagnosed in the United States this year, but the overall rate of colon or rectal cancer diagnoses have dropped ...

TUCSON, Ariz. (KVOA) - The Cologuard Classic by Exact Sciences is offering golf fans a unique opportunity to support the local community while enjoying top-tier golf. Fans can receive free general ...

Colorectal cancer rates rose among younger adults; screening starts at 45. Blood-based tests like Shield offer less invasive detection to reach unscreened. Advocacy and education aim to expand access ...

MONTGOMERY, Ala. (WSFA) - November is National Family Health History Month, and doctors say now is the time to get serious about colon cancer screenings. A new option is making the process easier and ...

Abbott agreed to acquire Exact Sciences for $105 a share, representing a total equity value of about $21 billion. The transaction gives Exact Sciences exposure to the fast-growing cancer screening ...

Abbott announced Wednesday it will acquire Exact Sciences for approximately $21 billion in cash, positioning the healthcare giant to lead in the fast growing cancer screening and precision oncology ...